Hubei Biocause Pharmaceutical Co., Ltd. (SZSE:000627) recently said that one of its units plans to sell up to 419 million shares, representing 14.45% stake in Tianjin Tianhai Investment Co., Ltd. (SHSE:900938).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 CNY | -0.46% |
|
-2.27% | -17.94% |
1st Jan change | Capi. | |
---|---|---|
-17.94% | 81Cr | |
+18.66% | 11TCr | |
-4.51% | 3TCr | |
+5.38% | 2.09TCr | |
-9.61% | 1.91TCr | |
-3.11% | 1.75TCr | |
+22.84% | 1.73TCr | |
+16.51% | 1.31TCr | |
+4.46% | 1.27TCr | |
+28.83% | 923.86Cr |
- Stock Market
- Equities
- 600751 Stock
- News HNA Technology Co.,Ltd.
- Hubei Biocause Pharmaceutical To Sell 14.45% Stake In Tianjin Tianhai Investment